Dec 31, 2011

United Therapeutics Q4 2011 Earnings Report

Total Revenue
$195M
Previous year: $164M
+19.2%
EPS
$0.8
Previous year: $0.16
+400.0%
Gross Profit
$170M
Previous year: $146M
+16.1%
Cash and Equivalents
$168M
Previous year: $252M
-33.4%
Free Cash Flow
$52.4M
Previous year: $33.8M
+54.9%
Total Assets
$1.52B
Previous year: $1.43B
+6.0%

United Therapeutics

United Therapeutics